Latest News-CBC Group Investment Management, Ltd. Mediaroom_Page

Jadeite Medicines Receives Orphan Drug Designation for Odevixibat in Progressive Familial Intrahepatic Cholestasis (PFIC) from the Ministry of Health, Labour and Welfare of Japan and will also initiate Phase 3 Trial of Odevixibat in PFIC in Japan

TOKYO, June 20, 2023 /PRNewswire/ -- Jadeite Medicines Inc., (Jadeite Medicines) a clinical stage b...

2023-06-21 09:00 2817

CBC GROUP RELEASES 2022 ESG REPORT

Guided by the firm's commitment to drive positive and meaningful impact while delivering better he...

2023-06-01 10:00 2351

Hasten Biopharma Acquires Commercial Rights in China for Roche's Antibiotic Rocephin®

The acquisition will deliver strong commercial synergy with Hasten's current critical care portfoli...

2023-05-04 14:00 2110

CBC GROUP AND MUBADALA CO-LEAD US$315 MILLION FUNDRAISING ROUND FOR HASTEN BIOPHARMA

Proceeds raised will be used to fund future acquisitions, and fuel business development of innovati...

2023-04-20 13:00 2201

CBC Group Appoints Healthcare Veteran Abbas Hussain as Operating Partner

SINGAPORE, March 31, 2023 /PRNewswire/ -- Singapore-headquartered asset management firm, CBC Group ...

2023-04-01 10:00 3683

RVAC Medicines announces research collaboration with University of Pennsylvania mRNA Vaccine Pioneer

BOSTON, March 17, 2023 /PRNewswire/ -- RVAC Medicines (US), Inc., a messenger RNA (mRNA) technology...

2023-03-17 21:00 3844

RVAC Medicines Secures HSA Approval to Initiate Phase 1B Clinical Trial in Singapore

SINGAPORE, Feb. 20, 2023 /PRNewswire/ -- RVAC Medicines Pte. Ltd. (RVAC), a messenger RNA (mRNA) te...

2023-02-21 10:00 1924

CBC Group Appoints Chief Operating Officer, Strengthening the Firm's Global Operational Capabilities

The former BlackRock and Goldman Sachs executive will oversee the firm's business management functi...

2023-02-01 20:18 2064

Navigating a perfect storm - driving access to healthcare in emerging markets

* Healthcare demand and expenditure in Southeast Asia are set to increase rapidly amidst rising a...

2022-11-30 15:00 1619

RVAC MEDICINES AND A*STAR TO BUILD CAPABILITIES FOR mRNA PRODUCTION IN SINGAPORE

SINGAPORE, Nov. 20, 2022 /PRNewswire/ -- RVAC Medicines Pte. Ltd. (RVAC), a messenger RNA (mRNA) te...

2022-11-21 10:00 2248

CBC-backed ABio-X appoints pharmaceutical and healthcare veteran Dr. Jeffrey Jonas as CEO

WALTHAM, Mass., Nov. 10, 2022 /PRNewswire/ -- ABio-X, the Massachusetts-based biotech incubation p...

2022-11-10 21:00 2499

CBC Healthcare Infrastructure Platform acquires prime industrial land in Shanghai to develop a high-specifications life science park

* 83.76 mu plot within the Life Science zone of the Qingpu Industrial Park, Shanghai Development ...

2022-11-01 11:00 1855

RVAC Medicines Initiates First-in-Human Clinical Trials for mRNA COVID-19 Vaccine Candidates

SINGAPORE, Sept. 21, 2022 /PRNewswire/ -- RVAC Medicines Pte. Ltd., a messenger RNA (mRNA) technolo...

2022-09-22 10:00 1593

CBC Welcomes Former Allergan CEO Brent Saunders to Join Hugel Board as Executive Chair

* Saunders brings decades of healthcare leadership experience, and plans to propel Korea's #1 med...

2022-05-20 15:00 2004

RVAC Medicines, a CBC-Incubated mRNA Platform Company, Raises US$140 Million to Expand R&D and Manufacturing Capacity

Series B financing led by CBC with participation from Temasek's Pavilion Capital, EDBI and GS Holdi...

2022-04-27 10:00 1865

ENSEM Therapeutics, a CBC Group-Incubated Biopharma Company, Raises $67 Million in Series A Financing to Develop Small Molecule Medicines for Difficult-to-Drug Targets

BOSTON, April 6, 2022 /PRNewswire/ -- ENSEM Therapeutics Inc. (ENSEM), a Boston -based biotechnology...

2022-04-07 04:00 1882

CBC Group-backed Hasten Biopharma successfully completes acquisition of five cardiovascular and metabolism drugs from Takeda

* CBC Group continues to expand its global healthcare ecosystem to fulfil unmet medical needs *...

2022-03-31 15:05 1683

Nuance Pharma Announces License and Supply Agreement with Bavarian Nordic on the Development and Commercialization of Respiratory Syncytial Virus (RSV) Vaccine for Adults in China and Selected Asian Markets

* Bavarian Nordic to receive up to USD 225 million in upfront and milestone payments in addition ...

2022-03-21 16:20 1615

Nuance Pharma acquires Sino Health to further strengthen its commercial capabilities and expand pipelines

SHANGHAI, Jan. 6, 2022 /PRNewswire/ -- Nuance Pharma ("Nuance"or the "Company"), a specialty care f...

2022-01-06 14:45 2700

Aerogen Pharma Enters into Exclusive Agreements with Nuance Pharma to Advance Treatment of Respiratory Distress Syndrome in Premature Infants in China

SHANGHAI, Dec. 22, 2021 /PRNewswire/ -- Aerogen Pharma, a developer of innovative inhaled treatment...

2021-12-23 07:44 1938